Dror Ortho-Design
JERUSALEM, Israel · Biotechnology, Healthcare, Health Care
Dror Ortho-Design is also known as Aerodentis. Dror Orthodesign is developing Aerodentis which is a removable, part-day use, aesthetic custom-made orthodontic device. It is based on a revolutionary patent-pending method to move teeth into an ideal occlusion. Aerodentis is custom produced for each patient using the latest in 3D image software and scanning technology. With solutions for patients of
Key facts
- Headquarters
- JERUSALEM, Israel
- Employees
- Unknown
- Industries
- Biotechnology, Healthcare, Health Care
- Status
- Public (DROR)
- Website
- www.aerodentis.com
- Company page
Recent activity at Dror Ortho-Design
- : SEC 8-K (5.07): On September 23, 2026, Dror Ortho-Design, Inc. held a special meeting of stockholders focused on key corporate matters. At this meeting, 976,997,116 shares of common stock and 5,847,937 shares of Series A Convertible Preferred Stock were available for voting. Significant proposals were put forth as outlined in the definitive proxy statement filed earlier on September 9, 2026. These matters seek to engage stockholder approval and reflect the company's governance processes, potentially impacting the Company's future strategic direction.
- : SEC 8-K (1.01): On August 19, 2026, Dror Ortho-Design, Inc. entered into a Securities Purchase Agreement to sell Debentures worth $275,000 in a private placement, due on October 19, 2026. This agreement includes provisions for issuing Purchase Warrants to purchasers, contingent on the completion of a future public offering of the company's securities. The deal signifies a key funding strategy for Dror Ortho-Design as they prepare for their anticipated public offering, which could expand their capital base and support business operations.
- : SEC 8-K (1.01): On December 2, 2025, Dror Ortho-Design, Inc. entered into a Securities Purchase Agreement with multiple purchasers to sell Debentures totaling $200,000, which are due on February 2, 2026. This agreement includes the issuance of warrants to purchase common stock, contingent on a future public offering by the Company. The terms specify that if the Debentures remain outstanding at the time of the public offering closing date, the warrants issued will allow for the purchase of shares equal to 150% of the principal amounts of the Debentures. This transaction aims to provide the Company with necessary funding while potentially expanding its equity base in conjunction with the public offering, thereby impacting its capital structure strategically.
- : Dror Ortho-Design Partners with Aran R&D to Advance Production
- : Dror Ortho-Design Announces Updated Investor Presentation for ZSmile Platform
Leadership
- Chaim Hurvitz, Acting Director Of Enforcement Directorate
- Yehuda Englander, Acting Director Of Enforcement Directorate
- Chaim Ravad, Acting Director Of Enforcement Directorate
- Moshe Shvets, Acting Director Of Enforcement Directorate
- Eliyahu Haddad, Acting Director Of Enforcement Directorate
Verified email and direct lines for Dror Ortho-Design’s decision-makers are on Fundz. See plans
Companies similar to Dror Ortho-Design
- JenaValve · Biotechnology, Healthcare, Health Care, Information Technology, Manufacturing, Medical Device
- Monteris Medical · Biotechnology, Healthcare, Health Care, Manufacturing, Medical, Medical Device
- SynerFuse, Inc. · Biotechnology, Healthcare, Health Care, Manufacturing, Medical, Medical Device
- RIVANNA · Biotechnology, Healthcare, Health Care, Manufacturing, Medical, Medical Device
- Swiss Technology Group · Biotechnology, Health Care, Information Technology, Manufacturing, Medical, Medical Device
About Dror Ortho-Design: questions and answers
What does Dror Ortho-Design do?
Dror Ortho-Design is also known as Aerodentis. Dror Orthodesign is developing Aerodentis which is a removable, part-day use, aesthetic custom-made orthodontic device. It is based on a revolutionary patent-pending method to move teeth into an ideal occlusion. Aerodentis is custom produced for each patient using the latest in 3D image software and scanning technology. With solutions for patients of
Where is Dror Ortho-Design headquartered?
Dror Ortho-Design is headquartered in JERUSALEM, Israel.
What is the latest news on Dror Ortho-Design?
On Sep 23, 2026, SEC 8-K (5.07): On September 23, 2026, Dror Ortho-Design, Inc. held a special meeting of stockholders focused on key corporate matters. At this meeting, 976,997,116 shares of common stock and 5,847,937 shares of Series A Convertible Preferred Stock were available for voting. Significant proposals we
Is Dror Ortho-Design a public company?
Yes. Dror Ortho-Design is publicly traded under the ticker DROR.
Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy